Mallinckrodt to Fund $10M in Research at Wash University

ST. LOUIS (AP) — Pharmaceutical manufacturer Mallinckrodt has announced plans to spend up to $10 million over five years to fund research at the Washington University School of Medicine in St. Louis. The St. Louis Post-Dispatch reports that the partnership will fund projects that have a focus on rare diseases. Mallinckrodt’s Chief Scientific Officer, Dr. Steven…